nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—CYP3A4—breast cancer	0.178	0.546	CbGaD
Ticagrelor—ABCB1—breast cancer	0.148	0.454	CbGaD
Ticagrelor—ABCB1—Toremifene—breast cancer	0.0403	0.0909	CbGbCtD
Ticagrelor—CYP3A4—Exemestane—breast cancer	0.0349	0.0786	CbGbCtD
Ticagrelor—CYP3A4—Letrozole—breast cancer	0.0296	0.0668	CbGbCtD
Ticagrelor—ABCB1—Lapatinib—breast cancer	0.0294	0.0663	CbGbCtD
Ticagrelor—CYP3A4—Anastrozole—breast cancer	0.0264	0.0596	CbGbCtD
Ticagrelor—CYP3A4—Toremifene—breast cancer	0.0242	0.0545	CbGbCtD
Ticagrelor—CYP3A4—Fulvestrant—breast cancer	0.0225	0.0507	CbGbCtD
Ticagrelor—CYP3A4—Thiotepa—breast cancer	0.02	0.0451	CbGbCtD
Ticagrelor—CYP3A4—Ixabepilone—breast cancer	0.0183	0.0413	CbGbCtD
Ticagrelor—CYP3A4—Lapatinib—breast cancer	0.0176	0.0397	CbGbCtD
Ticagrelor—ABCB1—Vinorelbine—breast cancer	0.0163	0.0368	CbGbCtD
Ticagrelor—ABCB1—Tamoxifen—breast cancer	0.0147	0.0332	CbGbCtD
Ticagrelor—ABCB1—Mitoxantrone—breast cancer	0.0144	0.0324	CbGbCtD
Ticagrelor—CYP3A4—Raloxifene—breast cancer	0.0134	0.0301	CbGbCtD
Ticagrelor—ABCB1—Gemcitabine—breast cancer	0.0127	0.0286	CbGbCtD
Ticagrelor—ABCB1—Paclitaxel—breast cancer	0.0115	0.0259	CbGbCtD
Ticagrelor—ABCB1—Irinotecan—breast cancer	0.0113	0.0255	CbGbCtD
Ticagrelor—ABCB1—Vinblastine—breast cancer	0.0101	0.0227	CbGbCtD
Ticagrelor—CYP3A4—Vinorelbine—breast cancer	0.00978	0.022	CbGbCtD
Ticagrelor—CYP3A4—Tamoxifen—breast cancer	0.00882	0.0199	CbGbCtD
Ticagrelor—CYP3A4—Mitoxantrone—breast cancer	0.00861	0.0194	CbGbCtD
Ticagrelor—ABCB1—Docetaxel—breast cancer	0.00829	0.0187	CbGbCtD
Ticagrelor—CYP3A4—Paclitaxel—breast cancer	0.00687	0.0155	CbGbCtD
Ticagrelor—CYP3A4—Irinotecan—breast cancer	0.00678	0.0153	CbGbCtD
Ticagrelor—ABCB1—Doxorubicin—breast cancer	0.00618	0.0139	CbGbCtD
Ticagrelor—CYP3A4—Vinblastine—breast cancer	0.00602	0.0136	CbGbCtD
Ticagrelor—ABCB1—Methotrexate—breast cancer	0.00598	0.0135	CbGbCtD
Ticagrelor—CYP3A4—Docetaxel—breast cancer	0.00497	0.0112	CbGbCtD
Ticagrelor—CYP3A4—Doxorubicin—breast cancer	0.0037	0.00835	CbGbCtD
Ticagrelor—Rash—Thiotepa—breast cancer	6.35e-05	0.000359	CcSEcCtD
Ticagrelor—Dermatitis—Thiotepa—breast cancer	6.34e-05	0.000359	CcSEcCtD
Ticagrelor—Dyspnoea—Paclitaxel—breast cancer	6.32e-05	0.000357	CcSEcCtD
Ticagrelor—Headache—Thiotepa—breast cancer	6.31e-05	0.000357	CcSEcCtD
Ticagrelor—Chest pain—Docetaxel—breast cancer	6.27e-05	0.000354	CcSEcCtD
Ticagrelor—Loss of consciousness—Capecitabine—breast cancer	6.27e-05	0.000354	CcSEcCtD
Ticagrelor—Nausea—Vinorelbine—breast cancer	6.26e-05	0.000354	CcSEcCtD
Ticagrelor—Dyspepsia—Paclitaxel—breast cancer	6.24e-05	0.000353	CcSEcCtD
Ticagrelor—Asthenia—Irinotecan—breast cancer	6.24e-05	0.000353	CcSEcCtD
Ticagrelor—Asthenia—Mitoxantrone—breast cancer	6.24e-05	0.000353	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.23e-05	0.000352	CcSEcCtD
Ticagrelor—Cough—Capecitabine—breast cancer	6.22e-05	0.000352	CcSEcCtD
Ticagrelor—Hypertension—Capecitabine—breast cancer	6.16e-05	0.000348	CcSEcCtD
Ticagrelor—Hypersensitivity—Fluorouracil—breast cancer	6.14e-05	0.000347	CcSEcCtD
Ticagrelor—Haemoglobin—Methotrexate—breast cancer	6.13e-05	0.000346	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Paclitaxel—breast cancer	6.12e-05	0.000346	CcSEcCtD
Ticagrelor—Fatigue—Paclitaxel—breast cancer	6.11e-05	0.000346	CcSEcCtD
Ticagrelor—Haemorrhage—Methotrexate—breast cancer	6.1e-05	0.000345	CcSEcCtD
Ticagrelor—Asthenia—Gemcitabine—breast cancer	6.08e-05	0.000344	CcSEcCtD
Ticagrelor—Chest pain—Capecitabine—breast cancer	6.07e-05	0.000343	CcSEcCtD
Ticagrelor—Constipation—Paclitaxel—breast cancer	6.06e-05	0.000343	CcSEcCtD
Ticagrelor—Haematuria—Epirubicin—breast cancer	6.06e-05	0.000343	CcSEcCtD
Ticagrelor—Confusional state—Docetaxel—breast cancer	6.06e-05	0.000343	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	6.03e-05	0.000341	CcSEcCtD
Ticagrelor—Urinary tract disorder—Methotrexate—breast cancer	6.02e-05	0.00034	CcSEcCtD
Ticagrelor—Epistaxis—Epirubicin—breast cancer	6e-05	0.000339	CcSEcCtD
Ticagrelor—Pruritus—Gemcitabine—breast cancer	5.99e-05	0.000339	CcSEcCtD
Ticagrelor—Nausea—Thiotepa—breast cancer	5.98e-05	0.000338	CcSEcCtD
Ticagrelor—Urethral disorder—Methotrexate—breast cancer	5.98e-05	0.000338	CcSEcCtD
Ticagrelor—Diarrhoea—Mitoxantrone—breast cancer	5.95e-05	0.000336	CcSEcCtD
Ticagrelor—Diarrhoea—Irinotecan—breast cancer	5.95e-05	0.000336	CcSEcCtD
Ticagrelor—Shock—Docetaxel—breast cancer	5.91e-05	0.000334	CcSEcCtD
Ticagrelor—Nervous system disorder—Docetaxel—breast cancer	5.9e-05	0.000333	CcSEcCtD
Ticagrelor—Pruritus—Fluorouracil—breast cancer	5.89e-05	0.000333	CcSEcCtD
Ticagrelor—Confusional state—Capecitabine—breast cancer	5.87e-05	0.000332	CcSEcCtD
Ticagrelor—Feeling abnormal—Paclitaxel—breast cancer	5.84e-05	0.00033	CcSEcCtD
Ticagrelor—Skin disorder—Docetaxel—breast cancer	5.84e-05	0.00033	CcSEcCtD
Ticagrelor—Bradycardia—Epirubicin—breast cancer	5.81e-05	0.000328	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Paclitaxel—breast cancer	5.8e-05	0.000328	CcSEcCtD
Ticagrelor—Diarrhoea—Gemcitabine—breast cancer	5.8e-05	0.000328	CcSEcCtD
Ticagrelor—Dizziness—Irinotecan—breast cancer	5.75e-05	0.000325	CcSEcCtD
Ticagrelor—Haemoglobin—Epirubicin—breast cancer	5.74e-05	0.000324	CcSEcCtD
Ticagrelor—Shock—Capecitabine—breast cancer	5.73e-05	0.000324	CcSEcCtD
Ticagrelor—Nervous system disorder—Capecitabine—breast cancer	5.71e-05	0.000323	CcSEcCtD
Ticagrelor—Haemorrhage—Epirubicin—breast cancer	5.71e-05	0.000323	CcSEcCtD
Ticagrelor—Eye disorder—Methotrexate—breast cancer	5.7e-05	0.000322	CcSEcCtD
Ticagrelor—Diarrhoea—Fluorouracil—breast cancer	5.7e-05	0.000322	CcSEcCtD
Ticagrelor—Cardiac disorder—Methotrexate—breast cancer	5.66e-05	0.00032	CcSEcCtD
Ticagrelor—Skin disorder—Capecitabine—breast cancer	5.65e-05	0.00032	CcSEcCtD
Ticagrelor—Urinary tract disorder—Epirubicin—breast cancer	5.64e-05	0.000319	CcSEcCtD
Ticagrelor—Oedema peripheral—Epirubicin—breast cancer	5.62e-05	0.000318	CcSEcCtD
Ticagrelor—Hypotension—Docetaxel—breast cancer	5.62e-05	0.000318	CcSEcCtD
Ticagrelor—Haematuria—Doxorubicin—breast cancer	5.61e-05	0.000317	CcSEcCtD
Ticagrelor—Connective tissue disorder—Epirubicin—breast cancer	5.61e-05	0.000317	CcSEcCtD
Ticagrelor—Abdominal pain—Paclitaxel—breast cancer	5.61e-05	0.000317	CcSEcCtD
Ticagrelor—Body temperature increased—Paclitaxel—breast cancer	5.61e-05	0.000317	CcSEcCtD
Ticagrelor—Urethral disorder—Epirubicin—breast cancer	5.59e-05	0.000316	CcSEcCtD
Ticagrelor—Epistaxis—Doxorubicin—breast cancer	5.55e-05	0.000314	CcSEcCtD
Ticagrelor—Angiopathy—Methotrexate—breast cancer	5.53e-05	0.000313	CcSEcCtD
Ticagrelor—Vomiting—Irinotecan—breast cancer	5.53e-05	0.000313	CcSEcCtD
Ticagrelor—Vomiting—Mitoxantrone—breast cancer	5.53e-05	0.000313	CcSEcCtD
Ticagrelor—Immune system disorder—Methotrexate—breast cancer	5.51e-05	0.000311	CcSEcCtD
Ticagrelor—Dizziness—Fluorouracil—breast cancer	5.51e-05	0.000311	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methotrexate—breast cancer	5.5e-05	0.000311	CcSEcCtD
Ticagrelor—Rash—Mitoxantrone—breast cancer	5.48e-05	0.00031	CcSEcCtD
Ticagrelor—Rash—Irinotecan—breast cancer	5.48e-05	0.00031	CcSEcCtD
Ticagrelor—Dermatitis—Mitoxantrone—breast cancer	5.48e-05	0.00031	CcSEcCtD
Ticagrelor—Dermatitis—Irinotecan—breast cancer	5.48e-05	0.00031	CcSEcCtD
Ticagrelor—Headache—Mitoxantrone—breast cancer	5.45e-05	0.000308	CcSEcCtD
Ticagrelor—Headache—Irinotecan—breast cancer	5.45e-05	0.000308	CcSEcCtD
Ticagrelor—Hypotension—Capecitabine—breast cancer	5.44e-05	0.000307	CcSEcCtD
Ticagrelor—Paraesthesia—Docetaxel—breast cancer	5.4e-05	0.000305	CcSEcCtD
Ticagrelor—Vomiting—Gemcitabine—breast cancer	5.39e-05	0.000304	CcSEcCtD
Ticagrelor—Bradycardia—Doxorubicin—breast cancer	5.38e-05	0.000304	CcSEcCtD
Ticagrelor—Dyspnoea—Docetaxel—breast cancer	5.36e-05	0.000303	CcSEcCtD
Ticagrelor—Mental disorder—Methotrexate—breast cancer	5.34e-05	0.000302	CcSEcCtD
Ticagrelor—Rash—Gemcitabine—breast cancer	5.34e-05	0.000302	CcSEcCtD
Ticagrelor—Dermatitis—Gemcitabine—breast cancer	5.34e-05	0.000302	CcSEcCtD
Ticagrelor—Eye disorder—Epirubicin—breast cancer	5.33e-05	0.000301	CcSEcCtD
Ticagrelor—Malnutrition—Methotrexate—breast cancer	5.31e-05	0.0003	CcSEcCtD
Ticagrelor—Haemoglobin—Doxorubicin—breast cancer	5.31e-05	0.0003	CcSEcCtD
Ticagrelor—Headache—Gemcitabine—breast cancer	5.31e-05	0.0003	CcSEcCtD
Ticagrelor—Cardiac disorder—Epirubicin—breast cancer	5.3e-05	0.000299	CcSEcCtD
Ticagrelor—Vomiting—Fluorouracil—breast cancer	5.3e-05	0.000299	CcSEcCtD
Ticagrelor—Dyspepsia—Docetaxel—breast cancer	5.29e-05	0.000299	CcSEcCtD
Ticagrelor—Haemorrhage—Doxorubicin—breast cancer	5.28e-05	0.000298	CcSEcCtD
Ticagrelor—Rash—Fluorouracil—breast cancer	5.25e-05	0.000297	CcSEcCtD
Ticagrelor—Dermatitis—Fluorouracil—breast cancer	5.25e-05	0.000297	CcSEcCtD
Ticagrelor—Paraesthesia—Capecitabine—breast cancer	5.23e-05	0.000295	CcSEcCtD
Ticagrelor—Hypersensitivity—Paclitaxel—breast cancer	5.23e-05	0.000295	CcSEcCtD
Ticagrelor—Headache—Fluorouracil—breast cancer	5.22e-05	0.000295	CcSEcCtD
Ticagrelor—Urinary tract disorder—Doxorubicin—breast cancer	5.21e-05	0.000295	CcSEcCtD
Ticagrelor—Oedema peripheral—Doxorubicin—breast cancer	5.2e-05	0.000294	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Docetaxel—breast cancer	5.19e-05	0.000293	CcSEcCtD
Ticagrelor—Connective tissue disorder—Doxorubicin—breast cancer	5.19e-05	0.000293	CcSEcCtD
Ticagrelor—Dyspnoea—Capecitabine—breast cancer	5.19e-05	0.000293	CcSEcCtD
Ticagrelor—Fatigue—Docetaxel—breast cancer	5.18e-05	0.000293	CcSEcCtD
Ticagrelor—Angiopathy—Epirubicin—breast cancer	5.18e-05	0.000293	CcSEcCtD
Ticagrelor—Urethral disorder—Doxorubicin—breast cancer	5.18e-05	0.000293	CcSEcCtD
Ticagrelor—Nausea—Irinotecan—breast cancer	5.17e-05	0.000292	CcSEcCtD
Ticagrelor—Nausea—Mitoxantrone—breast cancer	5.17e-05	0.000292	CcSEcCtD
Ticagrelor—Immune system disorder—Epirubicin—breast cancer	5.15e-05	0.000291	CcSEcCtD
Ticagrelor—Mediastinal disorder—Epirubicin—breast cancer	5.14e-05	0.000291	CcSEcCtD
Ticagrelor—Constipation—Docetaxel—breast cancer	5.14e-05	0.000291	CcSEcCtD
Ticagrelor—Back pain—Methotrexate—breast cancer	5.13e-05	0.00029	CcSEcCtD
Ticagrelor—Dyspepsia—Capecitabine—breast cancer	5.12e-05	0.00029	CcSEcCtD
Ticagrelor—Asthenia—Paclitaxel—breast cancer	5.09e-05	0.000288	CcSEcCtD
Ticagrelor—Nausea—Gemcitabine—breast cancer	5.03e-05	0.000284	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Capecitabine—breast cancer	5.02e-05	0.000284	CcSEcCtD
Ticagrelor—Fatigue—Capecitabine—breast cancer	5.02e-05	0.000284	CcSEcCtD
Ticagrelor—Pruritus—Paclitaxel—breast cancer	5.02e-05	0.000284	CcSEcCtD
Ticagrelor—Mental disorder—Epirubicin—breast cancer	5e-05	0.000283	CcSEcCtD
Ticagrelor—Constipation—Capecitabine—breast cancer	4.98e-05	0.000281	CcSEcCtD
Ticagrelor—Malnutrition—Epirubicin—breast cancer	4.97e-05	0.000281	CcSEcCtD
Ticagrelor—Feeling abnormal—Docetaxel—breast cancer	4.95e-05	0.00028	CcSEcCtD
Ticagrelor—Nausea—Fluorouracil—breast cancer	4.95e-05	0.00028	CcSEcCtD
Ticagrelor—Eye disorder—Doxorubicin—breast cancer	4.93e-05	0.000279	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Docetaxel—breast cancer	4.92e-05	0.000278	CcSEcCtD
Ticagrelor—Cardiac disorder—Doxorubicin—breast cancer	4.9e-05	0.000277	CcSEcCtD
Ticagrelor—Diarrhoea—Paclitaxel—breast cancer	4.85e-05	0.000274	CcSEcCtD
Ticagrelor—Back pain—Epirubicin—breast cancer	4.81e-05	0.000272	CcSEcCtD
Ticagrelor—Feeling abnormal—Capecitabine—breast cancer	4.8e-05	0.000271	CcSEcCtD
Ticagrelor—Angiopathy—Doxorubicin—breast cancer	4.79e-05	0.000271	CcSEcCtD
Ticagrelor—Immune system disorder—Doxorubicin—breast cancer	4.77e-05	0.00027	CcSEcCtD
Ticagrelor—Vertigo—Methotrexate—breast cancer	4.77e-05	0.00027	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Capecitabine—breast cancer	4.76e-05	0.000269	CcSEcCtD
Ticagrelor—Mediastinal disorder—Doxorubicin—breast cancer	4.76e-05	0.000269	CcSEcCtD
Ticagrelor—Body temperature increased—Docetaxel—breast cancer	4.75e-05	0.000269	CcSEcCtD
Ticagrelor—Abdominal pain—Docetaxel—breast cancer	4.75e-05	0.000269	CcSEcCtD
Ticagrelor—Dizziness—Paclitaxel—breast cancer	4.69e-05	0.000265	CcSEcCtD
Ticagrelor—Cough—Methotrexate—breast cancer	4.63e-05	0.000262	CcSEcCtD
Ticagrelor—Mental disorder—Doxorubicin—breast cancer	4.63e-05	0.000262	CcSEcCtD
Ticagrelor—Body temperature increased—Capecitabine—breast cancer	4.6e-05	0.00026	CcSEcCtD
Ticagrelor—Abdominal pain—Capecitabine—breast cancer	4.6e-05	0.00026	CcSEcCtD
Ticagrelor—Malnutrition—Doxorubicin—breast cancer	4.6e-05	0.00026	CcSEcCtD
Ticagrelor—Chest pain—Methotrexate—breast cancer	4.52e-05	0.000255	CcSEcCtD
Ticagrelor—Vomiting—Paclitaxel—breast cancer	4.51e-05	0.000255	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.49e-05	0.000254	CcSEcCtD
Ticagrelor—Rash—Paclitaxel—breast cancer	4.47e-05	0.000253	CcSEcCtD
Ticagrelor—Dermatitis—Paclitaxel—breast cancer	4.47e-05	0.000253	CcSEcCtD
Ticagrelor—Vertigo—Epirubicin—breast cancer	4.46e-05	0.000252	CcSEcCtD
Ticagrelor—Syncope—Epirubicin—breast cancer	4.46e-05	0.000252	CcSEcCtD
Ticagrelor—Back pain—Doxorubicin—breast cancer	4.45e-05	0.000251	CcSEcCtD
Ticagrelor—Headache—Paclitaxel—breast cancer	4.44e-05	0.000251	CcSEcCtD
Ticagrelor—Hypersensitivity—Docetaxel—breast cancer	4.43e-05	0.00025	CcSEcCtD
Ticagrelor—Confusional state—Methotrexate—breast cancer	4.37e-05	0.000247	CcSEcCtD
Ticagrelor—Loss of consciousness—Epirubicin—breast cancer	4.37e-05	0.000247	CcSEcCtD
Ticagrelor—Cough—Epirubicin—breast cancer	4.34e-05	0.000245	CcSEcCtD
Ticagrelor—Asthenia—Docetaxel—breast cancer	4.31e-05	0.000244	CcSEcCtD
Ticagrelor—Hypertension—Epirubicin—breast cancer	4.29e-05	0.000242	CcSEcCtD
Ticagrelor—Hypersensitivity—Capecitabine—breast cancer	4.29e-05	0.000242	CcSEcCtD
Ticagrelor—Pruritus—Docetaxel—breast cancer	4.25e-05	0.00024	CcSEcCtD
Ticagrelor—Nervous system disorder—Methotrexate—breast cancer	4.25e-05	0.00024	CcSEcCtD
Ticagrelor—Chest pain—Epirubicin—breast cancer	4.23e-05	0.000239	CcSEcCtD
Ticagrelor—Nausea—Paclitaxel—breast cancer	4.21e-05	0.000238	CcSEcCtD
Ticagrelor—Skin disorder—Methotrexate—breast cancer	4.21e-05	0.000238	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.2e-05	0.000237	CcSEcCtD
Ticagrelor—Asthenia—Capecitabine—breast cancer	4.18e-05	0.000236	CcSEcCtD
Ticagrelor—Vertigo—Doxorubicin—breast cancer	4.13e-05	0.000233	CcSEcCtD
Ticagrelor—Syncope—Doxorubicin—breast cancer	4.12e-05	0.000233	CcSEcCtD
Ticagrelor—Pruritus—Capecitabine—breast cancer	4.12e-05	0.000233	CcSEcCtD
Ticagrelor—Diarrhoea—Docetaxel—breast cancer	4.11e-05	0.000232	CcSEcCtD
Ticagrelor—Confusional state—Epirubicin—breast cancer	4.09e-05	0.000231	CcSEcCtD
Ticagrelor—Hypotension—Methotrexate—breast cancer	4.05e-05	0.000229	CcSEcCtD
Ticagrelor—Loss of consciousness—Doxorubicin—breast cancer	4.04e-05	0.000228	CcSEcCtD
Ticagrelor—Cough—Doxorubicin—breast cancer	4.01e-05	0.000227	CcSEcCtD
Ticagrelor—Shock—Epirubicin—breast cancer	3.99e-05	0.000225	CcSEcCtD
Ticagrelor—Diarrhoea—Capecitabine—breast cancer	3.98e-05	0.000225	CcSEcCtD
Ticagrelor—Nervous system disorder—Epirubicin—breast cancer	3.98e-05	0.000225	CcSEcCtD
Ticagrelor—Dizziness—Docetaxel—breast cancer	3.98e-05	0.000225	CcSEcCtD
Ticagrelor—Hypertension—Doxorubicin—breast cancer	3.97e-05	0.000224	CcSEcCtD
Ticagrelor—Skin disorder—Epirubicin—breast cancer	3.94e-05	0.000223	CcSEcCtD
Ticagrelor—Chest pain—Doxorubicin—breast cancer	3.91e-05	0.000221	CcSEcCtD
Ticagrelor—Paraesthesia—Methotrexate—breast cancer	3.89e-05	0.00022	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.89e-05	0.00022	CcSEcCtD
Ticagrelor—Dyspnoea—Methotrexate—breast cancer	3.86e-05	0.000218	CcSEcCtD
Ticagrelor—Dizziness—Capecitabine—breast cancer	3.85e-05	0.000218	CcSEcCtD
Ticagrelor—Vomiting—Docetaxel—breast cancer	3.82e-05	0.000216	CcSEcCtD
Ticagrelor—Dyspepsia—Methotrexate—breast cancer	3.81e-05	0.000216	CcSEcCtD
Ticagrelor—Rash—Docetaxel—breast cancer	3.79e-05	0.000214	CcSEcCtD
Ticagrelor—Hypotension—Epirubicin—breast cancer	3.79e-05	0.000214	CcSEcCtD
Ticagrelor—Dermatitis—Docetaxel—breast cancer	3.79e-05	0.000214	CcSEcCtD
Ticagrelor—Confusional state—Doxorubicin—breast cancer	3.78e-05	0.000214	CcSEcCtD
Ticagrelor—Headache—Docetaxel—breast cancer	3.77e-05	0.000213	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Methotrexate—breast cancer	3.74e-05	0.000211	CcSEcCtD
Ticagrelor—Fatigue—Methotrexate—breast cancer	3.74e-05	0.000211	CcSEcCtD
Ticagrelor—Vomiting—Capecitabine—breast cancer	3.7e-05	0.000209	CcSEcCtD
Ticagrelor—Shock—Doxorubicin—breast cancer	3.69e-05	0.000209	CcSEcCtD
Ticagrelor—Nervous system disorder—Doxorubicin—breast cancer	3.68e-05	0.000208	CcSEcCtD
Ticagrelor—Rash—Capecitabine—breast cancer	3.67e-05	0.000207	CcSEcCtD
Ticagrelor—Dermatitis—Capecitabine—breast cancer	3.67e-05	0.000207	CcSEcCtD
Ticagrelor—Headache—Capecitabine—breast cancer	3.65e-05	0.000206	CcSEcCtD
Ticagrelor—Skin disorder—Doxorubicin—breast cancer	3.64e-05	0.000206	CcSEcCtD
Ticagrelor—Paraesthesia—Epirubicin—breast cancer	3.64e-05	0.000206	CcSEcCtD
Ticagrelor—Dyspnoea—Epirubicin—breast cancer	3.61e-05	0.000204	CcSEcCtD
Ticagrelor—Nausea—Docetaxel—breast cancer	3.57e-05	0.000202	CcSEcCtD
Ticagrelor—Feeling abnormal—Methotrexate—breast cancer	3.57e-05	0.000202	CcSEcCtD
Ticagrelor—Dyspepsia—Epirubicin—breast cancer	3.57e-05	0.000202	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methotrexate—breast cancer	3.54e-05	0.0002	CcSEcCtD
Ticagrelor—Hypotension—Doxorubicin—breast cancer	3.51e-05	0.000198	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Epirubicin—breast cancer	3.5e-05	0.000198	CcSEcCtD
Ticagrelor—Fatigue—Epirubicin—breast cancer	3.5e-05	0.000198	CcSEcCtD
Ticagrelor—Constipation—Epirubicin—breast cancer	3.47e-05	0.000196	CcSEcCtD
Ticagrelor—Nausea—Capecitabine—breast cancer	3.46e-05	0.000195	CcSEcCtD
Ticagrelor—Abdominal pain—Methotrexate—breast cancer	3.42e-05	0.000194	CcSEcCtD
Ticagrelor—Body temperature increased—Methotrexate—breast cancer	3.42e-05	0.000194	CcSEcCtD
Ticagrelor—Paraesthesia—Doxorubicin—breast cancer	3.37e-05	0.00019	CcSEcCtD
Ticagrelor—Dyspnoea—Doxorubicin—breast cancer	3.34e-05	0.000189	CcSEcCtD
Ticagrelor—Feeling abnormal—Epirubicin—breast cancer	3.34e-05	0.000189	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Epirubicin—breast cancer	3.32e-05	0.000187	CcSEcCtD
Ticagrelor—Dyspepsia—Doxorubicin—breast cancer	3.3e-05	0.000187	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Doxorubicin—breast cancer	3.24e-05	0.000183	CcSEcCtD
Ticagrelor—Fatigue—Doxorubicin—breast cancer	3.23e-05	0.000183	CcSEcCtD
Ticagrelor—Constipation—Doxorubicin—breast cancer	3.21e-05	0.000181	CcSEcCtD
Ticagrelor—Body temperature increased—Epirubicin—breast cancer	3.21e-05	0.000181	CcSEcCtD
Ticagrelor—Abdominal pain—Epirubicin—breast cancer	3.21e-05	0.000181	CcSEcCtD
Ticagrelor—Hypersensitivity—Methotrexate—breast cancer	3.19e-05	0.00018	CcSEcCtD
Ticagrelor—Asthenia—Methotrexate—breast cancer	3.11e-05	0.000176	CcSEcCtD
Ticagrelor—Feeling abnormal—Doxorubicin—breast cancer	3.09e-05	0.000175	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Doxorubicin—breast cancer	3.07e-05	0.000173	CcSEcCtD
Ticagrelor—Pruritus—Methotrexate—breast cancer	3.07e-05	0.000173	CcSEcCtD
Ticagrelor—Hypersensitivity—Epirubicin—breast cancer	2.99e-05	0.000169	CcSEcCtD
Ticagrelor—Abdominal pain—Doxorubicin—breast cancer	2.97e-05	0.000168	CcSEcCtD
Ticagrelor—Body temperature increased—Doxorubicin—breast cancer	2.97e-05	0.000168	CcSEcCtD
Ticagrelor—Diarrhoea—Methotrexate—breast cancer	2.96e-05	0.000168	CcSEcCtD
Ticagrelor—Asthenia—Epirubicin—breast cancer	2.91e-05	0.000164	CcSEcCtD
Ticagrelor—Pruritus—Epirubicin—breast cancer	2.87e-05	0.000162	CcSEcCtD
Ticagrelor—Dizziness—Methotrexate—breast cancer	2.87e-05	0.000162	CcSEcCtD
Ticagrelor—Diarrhoea—Epirubicin—breast cancer	2.77e-05	0.000157	CcSEcCtD
Ticagrelor—Hypersensitivity—Doxorubicin—breast cancer	2.76e-05	0.000156	CcSEcCtD
Ticagrelor—Vomiting—Methotrexate—breast cancer	2.75e-05	0.000156	CcSEcCtD
Ticagrelor—Rash—Methotrexate—breast cancer	2.73e-05	0.000154	CcSEcCtD
Ticagrelor—Dermatitis—Methotrexate—breast cancer	2.73e-05	0.000154	CcSEcCtD
Ticagrelor—Headache—Methotrexate—breast cancer	2.71e-05	0.000153	CcSEcCtD
Ticagrelor—Asthenia—Doxorubicin—breast cancer	2.69e-05	0.000152	CcSEcCtD
Ticagrelor—Dizziness—Epirubicin—breast cancer	2.68e-05	0.000152	CcSEcCtD
Ticagrelor—Pruritus—Doxorubicin—breast cancer	2.65e-05	0.00015	CcSEcCtD
Ticagrelor—Vomiting—Epirubicin—breast cancer	2.58e-05	0.000146	CcSEcCtD
Ticagrelor—Nausea—Methotrexate—breast cancer	2.57e-05	0.000145	CcSEcCtD
Ticagrelor—Diarrhoea—Doxorubicin—breast cancer	2.57e-05	0.000145	CcSEcCtD
Ticagrelor—Rash—Epirubicin—breast cancer	2.56e-05	0.000145	CcSEcCtD
Ticagrelor—Dermatitis—Epirubicin—breast cancer	2.55e-05	0.000144	CcSEcCtD
Ticagrelor—Headache—Epirubicin—breast cancer	2.54e-05	0.000144	CcSEcCtD
Ticagrelor—Dizziness—Doxorubicin—breast cancer	2.48e-05	0.00014	CcSEcCtD
Ticagrelor—Nausea—Epirubicin—breast cancer	2.41e-05	0.000136	CcSEcCtD
Ticagrelor—Vomiting—Doxorubicin—breast cancer	2.39e-05	0.000135	CcSEcCtD
Ticagrelor—Rash—Doxorubicin—breast cancer	2.37e-05	0.000134	CcSEcCtD
Ticagrelor—Dermatitis—Doxorubicin—breast cancer	2.36e-05	0.000134	CcSEcCtD
Ticagrelor—Headache—Doxorubicin—breast cancer	2.35e-05	0.000133	CcSEcCtD
Ticagrelor—Nausea—Doxorubicin—breast cancer	2.23e-05	0.000126	CcSEcCtD
Ticagrelor—ABCB1—Metabolism—APRT—breast cancer	1.73e-05	0.000325	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	1.73e-05	0.000325	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CAV1—breast cancer	1.73e-05	0.000324	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	1.73e-05	0.000324	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	1.71e-05	0.00032	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KDR—breast cancer	1.71e-05	0.00032	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	1.67e-05	0.000313	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	1.67e-05	0.000312	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ESR1—breast cancer	1.67e-05	0.000312	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FN1—breast cancer	1.65e-05	0.000308	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ESRRA—breast cancer	1.63e-05	0.000305	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ANGPTL4—breast cancer	1.63e-05	0.000305	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NFKBIA—breast cancer	1.63e-05	0.000305	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOTCH1—breast cancer	1.61e-05	0.000302	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.59e-05	0.000298	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	1.59e-05	0.000297	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CG—breast cancer	1.58e-05	0.000295	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KIT—breast cancer	1.58e-05	0.000295	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APC—breast cancer	1.58e-05	0.000295	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGF—breast cancer	1.56e-05	0.000292	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.55e-05	0.000291	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPI—breast cancer	1.55e-05	0.000289	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HADHB—breast cancer	1.55e-05	0.000289	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.54e-05	0.000288	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SYNJ2—breast cancer	1.52e-05	0.000284	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.51e-05	0.000283	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MAPK3—breast cancer	1.51e-05	0.000282	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.51e-05	0.000282	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.5e-05	0.00028	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BRAF—breast cancer	1.48e-05	0.000277	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDH1A1—breast cancer	1.48e-05	0.000276	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDH7A1—breast cancer	1.48e-05	0.000276	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.46e-05	0.000274	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.46e-05	0.000273	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF1—breast cancer	1.44e-05	0.00027	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT2—breast cancer	1.44e-05	0.00027	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EGFR—breast cancer	1.44e-05	0.000269	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.43e-05	0.000267	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NME1—breast cancer	1.41e-05	0.000265	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FHL2—breast cancer	1.41e-05	0.000265	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PHGDH—breast cancer	1.41e-05	0.000265	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADSL—breast cancer	1.41e-05	0.000265	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—UMPS—breast cancer	1.41e-05	0.000265	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NDUFS3—breast cancer	1.41e-05	0.000264	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.41e-05	0.000263	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—BRIP1—breast cancer	1.39e-05	0.00026	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HPSE—breast cancer	1.39e-05	0.00026	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LDHB—breast cancer	1.39e-05	0.00026	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CD—breast cancer	1.39e-05	0.000259	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CA—breast cancer	1.37e-05	0.000257	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.37e-05	0.000257	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SERPINE1—breast cancer	1.37e-05	0.000256	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—KRAS—breast cancer	1.36e-05	0.000254	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.35e-05	0.000253	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CHST9—breast cancer	1.33e-05	0.000248	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.32e-05	0.000247	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA3—breast cancer	1.31e-05	0.000246	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCC1—breast cancer	1.31e-05	0.000246	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMMR—breast cancer	1.31e-05	0.000246	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOS3—breast cancer	1.31e-05	0.000245	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARGC1B—breast cancer	1.27e-05	0.000238	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.27e-05	0.000237	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—COX11—breast cancer	1.26e-05	0.000235	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.25e-05	0.000233	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CA—breast cancer	1.25e-05	0.000233	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MDM2—breast cancer	1.24e-05	0.000232	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RAF1—breast cancer	1.24e-05	0.000232	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RELA—breast cancer	1.23e-05	0.00023	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ERBB2—breast cancer	1.22e-05	0.000229	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.21e-05	0.000227	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.21e-05	0.000226	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CB—breast cancer	1.21e-05	0.000226	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MTOR—breast cancer	1.21e-05	0.000226	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA4—breast cancer	1.2e-05	0.000225	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CA9—breast cancer	1.2e-05	0.000225	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.19e-05	0.000222	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA2—breast cancer	1.17e-05	0.000219	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPX2—breast cancer	1.17e-05	0.000219	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL8—breast cancer	1.16e-05	0.000217	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SULT1A1—breast cancer	1.16e-05	0.000217	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPX4—breast cancer	1.16e-05	0.000217	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HRAS—breast cancer	1.15e-05	0.000216	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CDA—breast cancer	1.15e-05	0.000215	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SHMT1—breast cancer	1.15e-05	0.000215	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN1B—breast cancer	1.13e-05	0.000212	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA1—breast cancer	1.13e-05	0.000212	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—IDH1—breast cancer	1.13e-05	0.000212	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.13e-05	0.000211	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AKT1—breast cancer	1.12e-05	0.00021	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.12e-05	0.00021	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NAT2—breast cancer	1.12e-05	0.000209	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CASP3—breast cancer	1.11e-05	0.000208	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2—breast cancer	1.11e-05	0.000208	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.11e-05	0.000207	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC2A5—breast cancer	1.11e-05	0.000207	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—breast cancer	1.1e-05	0.000207	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCND1—breast cancer	1.08e-05	0.000202	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—JUN—breast cancer	1.08e-05	0.000202	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CTNNB1—breast cancer	1.07e-05	0.0002	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APRT—breast cancer	1.07e-05	0.0002	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—breast cancer	1.05e-05	0.000196	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN1A—breast cancer	1.05e-05	0.000196	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTEN—breast cancer	1.04e-05	0.000195	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.03e-05	0.000193	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK8—breast cancer	1.02e-05	0.000191	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT1—breast cancer	1.02e-05	0.000191	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ESRRA—breast cancer	1e-05	0.000188	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ANGPTL4—breast cancer	1e-05	0.000188	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	9.96e-06	0.000186	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—DPYD—breast cancer	9.8e-06	0.000183	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MED12—breast cancer	9.8e-06	0.000183	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SRC—breast cancer	9.68e-06	0.000181	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDOA—breast cancer	9.65e-06	0.000181	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPI—breast cancer	9.53e-06	0.000178	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HADHB—breast cancer	9.53e-06	0.000178	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—breast cancer	9.43e-06	0.000176	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NCOA3—breast cancer	9.37e-06	0.000175	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STAT3—breast cancer	9.33e-06	0.000175	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC2A2—breast cancer	9.3e-06	0.000174	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTR—breast cancer	9.11e-06	0.000171	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCG2—breast cancer	9.11e-06	0.000171	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CPT1A—breast cancer	9.11e-06	0.000171	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDH1A1—breast cancer	9.09e-06	0.00017	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDH7A1—breast cancer	9.09e-06	0.00017	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HPGDS—breast cancer	8.94e-06	0.000167	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK3—breast cancer	8.92e-06	0.000167	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HBA1—breast cancer	8.88e-06	0.000166	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PHGDH—breast cancer	8.71e-06	0.000163	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADSL—breast cancer	8.71e-06	0.000163	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NME1—breast cancer	8.71e-06	0.000163	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—UMPS—breast cancer	8.71e-06	0.000163	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FHL2—breast cancer	8.71e-06	0.000163	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MYC—breast cancer	8.67e-06	0.000162	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTT1—breast cancer	8.67e-06	0.000162	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ACHE—breast cancer	8.67e-06	0.000162	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TGFB1—breast cancer	8.65e-06	0.000162	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HPSE—breast cancer	8.54e-06	0.00016	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—BRIP1—breast cancer	8.54e-06	0.00016	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LDHB—breast cancer	8.54e-06	0.00016	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGFR—breast cancer	8.48e-06	0.000159	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	8.41e-06	0.000157	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP17A1—breast cancer	8.21e-06	0.000154	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ENO1—breast cancer	8.12e-06	0.000152	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS1—breast cancer	8.12e-06	0.000152	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMMR—breast cancer	8.1e-06	0.000152	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA3—breast cancer	8.1e-06	0.000152	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCC1—breast cancer	8.1e-06	0.000152	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KRAS—breast cancer	8.01e-06	0.00015	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2D6—breast cancer	7.97e-06	0.000149	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.84e-06	0.000147	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NCOA2—breast cancer	7.82e-06	0.000146	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	7.6e-06	0.000142	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FASN—breast cancer	7.58e-06	0.000142	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—BCHE—breast cancer	7.55e-06	0.000141	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC5A5—breast cancer	7.46e-06	0.00014	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA4—breast cancer	7.41e-06	0.000139	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CA9—breast cancer	7.41e-06	0.000139	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CA—breast cancer	7.36e-06	0.000138	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA2—breast cancer	7.22e-06	0.000135	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPX2—breast cancer	7.22e-06	0.000135	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC2A1—breast cancer	7.2e-06	0.000135	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NQO1—breast cancer	7.2e-06	0.000135	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SULT1A1—breast cancer	7.13e-06	0.000133	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPX4—breast cancer	7.13e-06	0.000133	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TP53—breast cancer	7.12e-06	0.000133	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP3A4—breast cancer	7.03e-06	0.000131	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—IDH1—breast cancer	6.97e-06	0.00013	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA1—breast cancer	6.97e-06	0.00013	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP1B1—breast cancer	6.91e-06	0.000129	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NAT2—breast cancer	6.89e-06	0.000129	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	6.87e-06	0.000129	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HRAS—breast cancer	6.81e-06	0.000127	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSP90AA1—breast cancer	6.77e-06	0.000127	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NCOA1—breast cancer	6.59e-06	0.000123	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—breast cancer	6.52e-06	0.000122	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP19A1—breast cancer	6.49e-06	0.000122	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—STK11—breast cancer	6.49e-06	0.000122	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—DPYD—breast cancer	6.04e-06	0.000113	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MED12—breast cancer	6.04e-06	0.000113	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—COMT—breast cancer	6.04e-06	0.000113	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT1—breast cancer	6.01e-06	0.000113	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTP1—breast cancer	6.01e-06	0.000112	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDOA—breast cancer	5.95e-06	0.000111	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMOX1—breast cancer	5.93e-06	0.000111	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ITPR1—breast cancer	5.91e-06	0.000111	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NCOA3—breast cancer	5.77e-06	0.000108	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC2A2—breast cancer	5.73e-06	0.000107	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCG2—breast cancer	5.61e-06	0.000105	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CPT1A—breast cancer	5.61e-06	0.000105	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTR—breast cancer	5.61e-06	0.000105	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TYMS—breast cancer	5.59e-06	0.000105	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLA2G4A—breast cancer	5.52e-06	0.000103	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTM1—breast cancer	5.52e-06	0.000103	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NCOR1—breast cancer	5.52e-06	0.000103	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HPGDS—breast cancer	5.51e-06	0.000103	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HBA1—breast cancer	5.47e-06	0.000102	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ACHE—breast cancer	5.34e-06	9.99e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTT1—breast cancer	5.34e-06	9.99e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPX1—breast cancer	5.29e-06	9.89e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP1A1—breast cancer	5.23e-06	9.8e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ERCC2—breast cancer	5.19e-06	9.71e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP17A1—breast cancer	5.06e-06	9.46e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ENO1—breast cancer	5e-06	9.37e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS1—breast cancer	5e-06	9.37e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2D6—breast cancer	4.91e-06	9.18e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTHFR—breast cancer	4.88e-06	9.13e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NCOA2—breast cancer	4.82e-06	9.01e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FASN—breast cancer	4.67e-06	8.74e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—BCHE—breast cancer	4.65e-06	8.71e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC5A5—breast cancer	4.6e-06	8.6e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CAV1—breast cancer	4.5e-06	8.42e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC2A1—breast cancer	4.44e-06	8.31e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NQO1—breast cancer	4.44e-06	8.31e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP1B1—breast cancer	4.26e-06	7.96e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.17e-06	7.81e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CG—breast cancer	4.1e-06	7.67e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NCOA1—breast cancer	4.06e-06	7.6e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP19A1—breast cancer	4e-06	7.49e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—STK11—breast cancer	4e-06	7.49e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—COMT—breast cancer	3.72e-06	6.96e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTP1—breast cancer	3.7e-06	6.93e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMOX1—breast cancer	3.65e-06	6.83e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ITPR1—breast cancer	3.64e-06	6.82e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CD—breast cancer	3.6e-06	6.74e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—breast cancer	3.56e-06	6.66e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCB1—breast cancer	3.5e-06	6.56e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TYMS—breast cancer	3.44e-06	6.44e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NOS3—breast cancer	3.4e-06	6.37e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NCOR1—breast cancer	3.4e-06	6.37e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.4e-06	6.37e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTM1—breast cancer	3.4e-06	6.37e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPX1—breast cancer	3.26e-06	6.1e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP1A1—breast cancer	3.22e-06	6.03e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ERCC2—breast cancer	3.2e-06	5.99e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CB—breast cancer	3.14e-06	5.88e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—breast cancer	3.11e-06	5.83e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTHFR—breast cancer	3.01e-06	5.63e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CAV1—breast cancer	2.77e-06	5.19e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTEN—breast cancer	2.71e-06	5.08e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CG—breast cancer	2.53e-06	4.73e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CD—breast cancer	2.22e-06	4.16e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—breast cancer	2.19e-06	4.1e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NOS3—breast cancer	2.1e-06	3.92e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CB—breast cancer	1.94e-06	3.62e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—breast cancer	1.92e-06	3.59e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CA—breast cancer	1.92e-06	3.58e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTEN—breast cancer	1.67e-06	3.13e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKT1—breast cancer	1.56e-06	2.93e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CA—breast cancer	1.18e-06	2.21e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKT1—breast cancer	9.64e-07	1.8e-05	CbGpPWpGaD
